TBPH icon

Theravance Biopharma

98 hedge funds and large institutions have $1.4B invested in Theravance Biopharma in 2016 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 16 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
-2
Holders Change %
-2%
% of All Funds
2.45%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.1%
New
22
Increased
42
Reduced
16
Closed
22
Calls
$1.8M
Puts
$744K
Net Calls
+$1.06M
Net Calls Change
+$1.76M
Name Holding Trade Value Shares
Change
Shares
Change %
Boston Partners
101
Boston Partners
Massachusetts
-$1.94M -53,533 Closed
Ameriprise
102
Ameriprise
Minnesota
-$1.68M -46,273 Closed
Dimensional Fund Advisors
103
Dimensional Fund Advisors
Texas
-$1.56M -43,018 Closed
CPIM
104
Columbia Partners Investment Management
Virginia
-$751K -20,750 Closed
FAM
105
Fred Alger Management
New York
-$689K -19,000 Closed
DC
106
Deere & Company
Illinois
-$526K -14,513 Closed
Axa
107
Axa
France
-$502K -13,841 Closed
HM
108
Harvest Management
New York
-$362K -10,000 Closed
Two Sigma Advisers
109
Two Sigma Advisers
New York
-$225K -6,200 Closed
TI
110
Trexquant Investment
Connecticut
-$217K -5,995 Closed
CG
111
Clinton Group
New York
-$217K -5,993 Closed
PNC Financial Services Group
112
PNC Financial Services Group
Pennsylvania
-$210K -5,800 Closed
AC
113
Amici Capital
New York
-$207K -5,705 Closed
BIM
114
Bogle Investment Management
Massachusetts
-$201K -5,550 Closed
SO
115
STRS Ohio
Ohio
-$134K -3,700 Closed
Group One Trading
116
Group One Trading
Illinois
-$50K -1,377 Closed
Simplex Trading
117
Simplex Trading
Illinois
-$29K -824 Closed
RBC
118
Roble Belko & Company
Pennsylvania
-$26K -714 Closed
Walleye Trading
119
Walleye Trading
New York
-$11K -300 Closed